Hong Kong
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 21.93 B |
Jan. 14, 2025 | USD 14.74 | 7.67% |
|
Hong Kong |
|
2 |
USD 6.70 B |
Jan. 14, 2025 | USD 0.37 | 1.03% |
|
Hong Kong |
|
3 |
USD 2.32 B |
Jan. 14, 2025 | USD 3.02 | 2.59% |
|
Hong Kong |
|
4 |
USD 528.94 M |
Jan. 14, 2025 | USD 0.83 | 3.07% |
|
Hong Kong |
|
5 |
USD 405.14 M |
Jan. 14, 2025 | USD 0.21 | 8.82% |
|
Hong Kong |
|
6 |
USD 157.28 M |
Jan. 14, 2025 | USD 0.26 | 2.03% |
|
Hong Kong |
|
7 |
USD 138.75 M |
Jan. 14, 2025 | USD 0.13 | -1.02% |
|
Hong Kong |
|
8 |
USD 70.98 M |
Jan. 14, 2025 | USD 5.81 | -1.19% |
|
Hong Kong |
|
9 |
USD 63.24 M |
Jan. 14, 2025 | USD 4.86 | -4.71% |
|
Hong Kong |
|
10 |
USD 40.85 M |
Jan. 14, 2025 | USD 0.39 | 0.30% |
|
Hong Kong |
|
11 |
USD 27.94 M |
Jan. 13, 2025 | USD 0.10 | 0.02% |
|
Hong Kong |
The Biotechnology company in Hong Kong with the highest Market Capitalization is BeiGene, Ltd. (HKSE: 6160.HK) at USD 21.93 B.
The Biotechnology company in Hong Kong with the lowest Market Capitalization is Yunnan Energy International Co. Limited (HKSE: 1298.HK) at USD 27.94 M.
The top 10 Biotechnology companies in Hong Kong by Market Capitalization are BeiGene, Ltd., Sino Biopharmaceutical Limited, HUTCHMED (China) Limited, Guangdong Hybribio Biotech Co.,Ltd., Frontage Holdings Corporation, KuangChi Science Limited, SinoMab BioScience Limited, Prenetics Global Limited, Regencell Bioscience Holdings Limited and Sirnaomics Ltd..
The bottom 10 Biotechnology companies in Hong Kong by Market Capitalization are Yunnan Energy International Co. Limited, Sirnaomics Ltd., Regencell Bioscience Holdings Limited, Prenetics Global Limited, SinoMab BioScience Limited, KuangChi Science Limited, Frontage Holdings Corporation, Guangdong Hybribio Biotech Co.,Ltd., HUTCHMED (China) Limited and Sino Biopharmaceutical Limited.